GlassScriptPhysician profile
Charles R Davis
NPI 1326136565
$2,016.20
in general payments reported to CMS, 2019-2025
10 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,667 · 2020: $40.90 · 2021: $80.69 · 2022: $12.09 · 2023: $64.37 · 2024: $33.48 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,699.13 | 2019-2023 | Da Vinci Surgical System |
| Medtronic, INC. | $84.96 | 2021-2025 | Transorb |
| Covidien LP | $45.95 | 2019 | |
| Ethicon US, LLC | $40.95 | 2025 | Echelon Circular |
| Molli Surgical (US) INC | $38.15 | 2023 | |
| Pfizer INC. | $33.48 | 2024 | |
| Teleflex LLC | $23.79 | 2019 | |
| Merck Sharp & Dohme LLC | $20.87 | 2021 | |
| Inspire Medical Systems, INC. | $16.83 | 2025 | Inspire |
| Innocoll Pharmaceuticals Limited | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.